Therefore, to highlight the potential clinical impact of our results, it is crucial to evaluate SPTBN1 expression levels and PTTG1 subcellular localization, along with their interaction, in different stages of seminoma to correlate these proteins’ crosstalk with tumor progression and the risk for disease relapse. This evidence concerns the gene SPTBN1 and seminoma.